PubMed=1503405
Bailly M., Dore J.-F.
Clonal drift and role of chromosome dosage in human melanoma metastatic cell lines: a statistical analysis.
Anticancer Res. 12:1163-1172(1992)

PubMed=8012932; DOI=10.1016/0304-3835(94)90197-x
Mey A., Berthier-Vergnes O., Apoil P.A., Dore J.-F., Revillard J.-P.
Expression of the galactose binding protein Mac-2 by human melanoma cell-lines.
Cancer Lett. 81:155-163(1994)

PubMed=8175891; DOI=10.1002/jcb.240540205
Zebda N., Bailly M., Brown S., Dore J.-F., Berthier-Vergnes O.
Expression of PNA-binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential.
J. Cell. Biochem. 54:161-173(1994)

PubMed=7874696; DOI=10.1016/0304-3835(94)03624-r
Thomas C.P., Buronfosse A., Portoukalian J., Fertil B.
Correlation between the radiosensitivity in vitro of clones and variants derived from a human melanoma cell line and their spontaneous metastatic potential in vivo.
Cancer Lett. 88:221-225(1995)

PubMed=9043018; DOI=10.1038/bjc.1997.115; PMCID=PMC2063334
Thomas C.P., Buronfosse A., Portoukalian J., Fertil B.
The gangliosides as a possible molecular coupling factor between the proportion of radiosensitive cells in vitro and the metastatic potential in vivo within a human melanoma cell line.
Br. J. Cancer 75:639-649(1997)

PubMed=11059782
Boukerche H., Baril P., Tabone E., Berard F., Sanhadji K., Balme B., Wolf F., Perrot H., Thomas L.
A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Cancer Res. 60:5848-5856(2000)